EUVIMEDEUVIMED entdecken
Crossref

Switchable PAMAM megamers for deep tumor penetration and enhanced cell uptake

Effat Nekoueifard, Fatemeh Radmanesh, Ibrahim Zarkesh, Marzieh Ebrahimi, Mohamad Raoufi, Hamid Sadeghi Abandansari, Hossein Baharvand, Rassoul Dinarvand

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.09.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Effat Nekoueifard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Department of Cell Engineering…. Hauptthemen laut MEDLINE: Doxorubicin, Dendrimers, Antibiotics, Antineoplastic, Drug Carriers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Iranian Council of Stem Cell Research and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles fabricated to deliver anticancer drugs are usually designed to present optimized tumor penetration and cell internalization. However, there are some barriers and difficulties with most current technologies. Herein, size and charge switchable polyamidoamine (PAMAM) megamers (SChPMs) were prepared for the delivery of doxorubicin (DOX). SChPMs were fabricated by connecting PAMAM dendrimers with pH-sensitive bonds and surface PEGylation. At pH 7.4, the size and surface charge of these nanocarriers were approximately 100 nm and + 0.75 mV, but at the acidic extracellular pH of tumor cells (pH 6.5), their size were reduced dramatically (15 nm) and their surface charge increased to +6.7 mV. Cell studies confirmed that alteration of the size and surface charge enhanced their penetration into multicellular spheroids and cell internalization. These megamers, in addition to delivering the drug to the deeper areas of the tumor, could powerfully overcome physiological resistance to anthracycline-based drugs. The nanocarrier revealed enhanced antitumoral activity in animal studies. Toxicology studies and histopathological assessments of vital tissues of 4 T1 tumor bearing mice indicated minimal tissue damage when DOX-loaded SChPMs (DSChPMs) were used. It can be concluded that the versatile and agile nanocarriers developed in this study could be considered for further investigations into their clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinDendrimersAntibiotics, AntineoplasticDrug CarriersAnimalsHumansCell Line, TumorNeoplasmsMiceNanoparticlesFemaleDrug LiberationHydrogen-Ion ConcentrationCell Survival

Stichwörter der Autor:innen

Anticancer nanocarriersCell internalizationPAMAM megamersPhysiological resistanceSize and charge switchable

Substanzen

DoxorubicinDendrimersPAMAM StarburstAntibiotics, AntineoplasticDrug Carriers

Autor:innen und Institutionen

  • Department of Pharmaceutical Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology…
  • Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Nanotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Cell Engineering, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran; Department of Cancer Medicine, Cell Science Research Center, Royan Institute for S…

Förderung

  • Iranian Council of Stem Cell Research and Technology

Zitieren

APA

Nekoueifard, E., Radmanesh, F., Zarkesh, I., Ebrahimi, M., Raoufi, M., Abandansari, H. S., Baharvand, H., & Dinarvand, R. (2024). Switchable PAMAM megamers for deep tumor penetration and enhanced cell uptake. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.09.031

Vancouver

Nekoueifard E, Radmanesh F, Zarkesh I, Ebrahimi M, Raoufi M, Abandansari HS, et al. Switchable PAMAM megamers for deep tumor penetration and enhanced cell uptake. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.09.031

BibTeX
@article{Nekoueifard2024,
  author = {Nekoueifard, Effat and Radmanesh, Fatemeh and Zarkesh, Ibrahim and Ebrahimi, Marzieh and Raoufi, Mohamad and Abandansari, Hamid Sadeghi and Baharvand, Hossein and Dinarvand, Rassoul},
  title = {Switchable PAMAM megamers for deep tumor penetration and enhanced cell uptake},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.09.031}
}
Kostenlos starten →